Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P080025/S351

lnterStim Therapy System, Verify Evaluation System

Medtronic Neuromodulation · Decision date Oct 6, 2026

MEDTECHLEDGER EXPLANATIONP080025/S351

What did the FDA approve?

The FDA record lists an approval decision dated 2026-10-06 for supplement P080025/S351 to Medtronic Neuromodulation's InterStim Therapy System and Verify Evaluation System, under product code QON for an implanted electrical device intended for treatment of fecal incontinence. The supplement type is Real-Time Process, with the stated reason 'Change Design/Components/Specifications/Material,' and the source statement describes 'a new stand-alone torque wrench kit configuration (Model B31020-T).'

The identifier shows this supplement sits under the original PMA P080025; it is not an approval of the whole system. The record presents the kit configuration as the changed item only. The source does not give the wrench's specifications, how it differs from prior configurations, or independent evidence of safety or clinical effectiveness for that change.

FDA approval order statement

a new stand-alone torque wrench kit configuration (Model B31020-T)
Regulatory pathway
PMA supplement
Supplement type
Real-Time Process
Clinical specialty
Gastroenterology, Urology
Decision date
Oct 6, 2026
FDA change category
Change Design/Components/Specifications/Material

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P080025/S351
Regulatory pathway
PMA supplement
Product code
QON
Decision code
APPR
Decision date
Oct 6, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Implanted electrical device intended for treatment of fecal incontinence.

Product code
QON
FDA device class
3

For the original device and its historical approval scope, see PMA P080025. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P080025 · Original PMA

    MEDTRONIC INTERSTIM SACRAL NERVE STIMULATION THERAPY SYSTEM

  2. P080025/S351 received

    Application receipt date recorded by FDA.

  3. P080025/S352 · Related supplement

    InterStim Therapy System, Verify Evaluation System

  4. P080025/S351 · FDA decision

    Real-Time Process

  5. P080025/S353 · Related supplement

    InterStim Therapy System, Verify Evaluation System

  6. P080025/S354 · Related supplement

    InterStim Therapy System, Verify Evaluation System (SNS Bowel Neurostimulator 97800), (SNS Bowel Neurostimulators Impl

Timeline entries are records held by MedtechLedger for P080025. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P080025

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic Neuromodulation

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
7000 Central Ave., NE, Ms Rcw225, Minneapolis, MN, 55432

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records